美國(guó)圣地亞哥的Abbiotec，是2007年新成立的一間生技公司，專(zhuān)業(yè)生產(chǎn)抗體類(lèi)相關(guān)產(chǎn)品，實(shí)驗(yàn)應(yīng)用范圍廣泛。研發(fā)陣容堅(jiān)強(qiáng)，對(duì)于抗體類(lèi)相關(guān)產(chǎn)品的生產(chǎn)及QC管理具深厚經(jīng)驗(yàn)。高質(zhì)量、創(chuàng)新與完整的產(chǎn)品線、合理的價(jià)格為Abbiotec*的堅(jiān)持與承諾。

Abbiotec公司是一家專(zhuān)注于開(kāi)發(fā)和商業(yè)化下一代抗體和試劑的生命科學(xué)研公司。Abbiotec的做法和商業(yè)概念誕生使Abbiotec有強(qiáng)烈的愿望去提供抗 druggable蛋白質(zhì)。Abbiotec的專(zhuān)有技術(shù)使我們能夠選擇，設(shè)計(jì)和產(chǎn)生抗體，裂解物，以及各種試劑以高度的技巧和效率，使研究人員能夠更好地集中精力對(duì)他們的實(shí)驗(yàn)設(shè)計(jì)和想法。

Abbiotec™ - From Biology to Discovery™ 
The sequencing of the human genome is considered as one of the most important milestone of the century reached by the Life Science research community. Biologists have estimated the total number of genes at 25,000. Now, the annotated human genome sequence creates a range of new possibilities for biomedical research and permits a more systematic approach to proteomics.
A concerted effort on the human proteome would certainly generate probes for identifying new targets for therapeutics. As researchers are focusing their efforts on determining the biological functions, interactions and regulation of the encoded proteins, Abbiotec is dedicated to developing cell biology-based research tools that assist scientific discoveries.

我公司常年低價(jià)提供此公司的產(chǎn)品，價(jià)格實(shí)惠，貨期快。